The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Isoproterenol
isoproterenol hydrochloride · ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL · Injection, Solution · Intracardiac; Intramuscular; Intravenous; Subcutaneous · Cipla USA Inc.
NDC 69097-0522-35 · 10 AMPULE in 1 CARTON / 5 mL in 1 AMPULE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$4,900.00
Reported to Texas DSHS · 2023 annual filing · Cipla USA Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Gland Pharma LimitedIndiaanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA210322
- TE code
- —
- Approval date
- Jun 12, 2018
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of isoproterenol hydrochloride (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Nordic Pharma, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ISOPROTERENOL HYDROCHLORIDE 1 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| KVK-Tech, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amphastar Pharmaceuticals, Inc. | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Nexus Pharmaceuticals LLC | ISOPROTERENOL HYDROCHLORIDE .2 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Isoproterenol — NDC 69097-0522-35," retrieved September 3, 2026, https://drugdashboards.com/drug/69097052235.
Free to cite with attribution — see how the data is put together.